Doug Kahlenbeck

Doug Kahlenbeck is a seasoned executive with extensive experience in financial, legal, and operational leadership across various sectors, particularly in healthcare and consulting. Currently serving as the Chief Financial Officer at Sogility since June 2022, Kahlenbeck previously held positions including Chief Executive Officer at Respiratory Health Technologies and xIR at Boomerang Ventures. Kahlenbeck's career features significant roles such as Chief Financial & Legal Officer at 3Oe Scientific, VP & COO at GoPath Laboratories, and Director at the American Society for Clinical Pathology. Kahlenbeck's legal expertise was honed as Corporate Counsel & Director of Legal Services at Renaissance LLC and Business & Legal Counsel at The Estridge Companies. Educational credentials include a JD in Corporate and Business Law from Indiana University Maurer School of Law and a BS in Economics, Finance, and Political Science from The Wharton School.